Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-07-20
2009-11-03
Marschel, Ardin (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S184000
Reexamination Certificate
active
07612057
ABSTRACT:
The invention provides supramolecular metal complexes as DNA cleaving agents. In the complexes, charge is transferred from one light absorbing metal (e.g. Ru or Os) to an electron accepting metal (e.g. Rh) via a bridging π-acceptor ligand. A bioactive metal-to-metal charge transfer state capable of cleaving DNA is thus generated. The complexes function when irradiated with low energy visible light with or without molecular oxygen.
REFERENCES:
patent: 5457195 (1995-10-01), Sessler et al.
patent: 6630128 (2003-10-01), Love et al.
J McCaughan Jr. “Photodynamic Therapy: A Review”. Drugs and Aging, 1999; 15(1):49-68.
Swavey et al. “Visible Light Induced Photocleavage of DNA by a Mixed-Metal Supramolecular Complex: [{(bpy)2Ru(dpp)}2RhCl2]5+”. Inorganic Chemistry, 2002; 41:6196-6198.
Lee Goldman, et al. (Editors): Cecil Textbook of Medicine; 21st Edition. W. B. Saunders Company, 2000. p. 1060-1074.
Brewer Karen
Swavey Shawn
Caesar Rivise Bernstein Cohen & Pokotilow Ltd.
Marschel Ardin
Royds Leslie A
Virginia Tech Intellectual Properties Inc.
LandOfFree
Supramolecular complexes as photoactivated DNA cleavage agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Supramolecular complexes as photoactivated DNA cleavage agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Supramolecular complexes as photoactivated DNA cleavage agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4131575